Diseases, Conditions, Syndromes

Trial success for liver disease breath test

Cambridge-based company Owlstone Medical, co-founded by alumnus Billy Boyle, has experienced trial success for its liver disease breath test, following a study involving patients from Addenbrooke's Hospital.

Diseases, Conditions, Syndromes

NAFLD increases the risk of early atherosclerotic lesions

A study presented today at the International Liver Congress 2013 – which evaluated the relationship between non-alcoholic fatty liver disease (NAFLD), early predictors of atherosclerosis and the 10-year Framingham risk ...

Diseases, Conditions, Syndromes

COPD readmission may be tied to unmodifiable risk factors

National efforts are underway to reduce 30-day readmission for chronic obstructive pulmonary disease (COPD); however, new research suggests that COPD readmissions may be related to risk factors that cannot be modified, including ...

page 4 from 4